Table 1.
Prospective studies on the prevention of HBV reactivation in lymphoma patients with resolved HBV infection
B-NHL indicates B-cell non-Hodgkin lymphoma; DLBCL, diffuse large B-cell lymphoma; CLL, chronic lymphocytic leukemia; NA, not available; ETV, entecavir; and RCT, randomized controlled trial.
